Activation of cortical tryptophan hydroxylase by acute morphine treatment: blockade by 6-hydroxydopamine.
Acute morphine produced a dose-dependent, naloxone-sensitive, reversible increase in tryptophan hydroxylase activity in low speed supernatants of midbrain, pons-medulla and cerebral cortex but not spinal cord. The increase in cortical enzyme activity was blocked by 6-hydroxydopamine pretreatment, could be reversed in vitro by incubation with alkaline phosphatase and was non-additive with the increase in enzyme activity induced in the presence of phosphorylating conditions. Morphine administration produced an increase in Vmax but no change in Km of cortical enzyme for substrate, tryptophan, or the artificial reduced pterin cofactor, 6-methyl-5,6,7,8-tetrahydropterin. The failure of morphine to increase spinal tryptophan hydroxylase activity despite enhancement of enzyme activity in medulla indicates regional differences in responsiveness of the enzyme to in vivo activation.
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D002540:Cerebral Cortex / Q000201:enzymology*; D002851:Chromatography, High Pressure Liquid; D004563:Electrochemistry; D004789:Enzyme Activation / Q000187:drug effects; D008401:Gas Chromatography-Mass Spectrometry; D006892:Hydroxydopamines / Q000494:pharmacology*; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007700:Kinetics; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D016627:Oxidopamine; D051381:Rats; D011919:Rats, Inbred Strains; D014365:Tryptophan Hydroxylase / Q000378:metabolism*
D006892:Hydroxydopamines; D009270:Naloxone; D006897:Hydroxyindoleacetic Acid; D009020:Morphine; D016627:Oxidopamine; D014365:Tryptophan Hydroxylase; D000469:Alkaline Phosphatase; D009638:Norepinephrine